Recent progress of antiviral therapy for coronavirus disease 2019

Mengmeng Zhao,Jishou Zhang,Hanli Li,Zhen Luo,Jing Ye,Yao Xu,Zhen Wang,Di Ye,Jianfang Liu,Dan Li,Menglong Wang,Jun Wan
DOI: https://doi.org/10.1016/j.ejphar.2020.173646
IF: 5.195
2021-01-01
European Journal of Pharmacology
Abstract:<p>The coronavirus disease 2019 (COVID-19) pandemic has become a global public health crisis, for which antiviral treatments are considered mainstream therapeutic approaches. With the development of this pandemic, the number of clinical studies on antiviral therapy, including remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir, ribavirin, arbidol, interferon, favipiravir, oseltamivir, nitazoxanide, nelfinavir, and camostat mesylate, has been increasing. However, the efficacy of these antiviral drugs for COVID-19 remains controversial. In this review, we summarize the recent progress and findings on antiviral therapies, aiming to provide clinical support for the management of COVID-19. In addition, we analyze the causes of controversy in antiviral drug research and discuss the quality of current studies on antiviral treatments. High-quality randomized clinical trials are required to demonstrate the efficacy and safety of antiviral drugs for the treatment of COVID-19.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to quantify the changes in atrial wall thickness during radiofrequency ablation by means of Intracardiac Echocardiography (ICE). Specifically, the researchers hope to use ICE technology to monitor the changes in atrial wall thickness during and after radiofrequency ablation, as well as the relationship between these changes and electrode temperature. This helps to better understand the specific impact of radiofrequency ablation on the atrial wall, thereby optimizing treatment regimens, reducing complications, and improving the safety and effectiveness of the operation. The research methods mentioned in the paper include conducting experiments in a porcine model, using a 9 - MHz imaging catheter to perform radiofrequency ablation at different parts of the heart (right atrium, superior vena cava, left atrium), and measuring the atrial wall thickness at baseline, 1 minute, 30 minutes, and 150 minutes after ablation. The results show that at all test points, the atrial wall thickness increased significantly after ablation, and this thickening had a significant correlation with electrode temperature (r = 0.55, p = 0.0001). In addition, the study also found that the thickening of the atrial wall was most obvious near the ablation site and gradually weakened as the distance increased. In summary, this study aims to provide more accurate guidance for clinicians by quantifying the changes in the atrial wall during radiofrequency ablation, in order to improve the effectiveness and safety of radiofrequency ablation surgery.